Cordio Medical

Medical Speech-processing Platform

Health Tech & Life Sciences
Active
Series C Or Yehuda, Israel Founded 2013
Last updated 2026-06-18
Total raised
$20.6M
Last: 2025-10
Stage
Series C
Founded
2013
Headcount
34
HQ
Or Yehuda, Israel
Sector
Health Tech & Life Sciences

About

Cordio Medical provides medical grade, groundbreaking solutions to monitor several health conditions by analyzing voice samples recorded in a simple smartphone app backed by sophisticated and proprietary algorithms allowing near real-time monitoring and early detection of condition deterioration.

Using only patient speech, sampled via mobile device, the Cordio HearO™ can sense fluid accumulation related to CHF and alert healthcare professionals in real-time. This is the only non-invasive, easy to use medical grade, CHF monitoring device that offers patients and caretakers peace of mind and a true sense of control.

Cordio Med's technologies are based on true speech signal processing technology, unique to each patient, augmented with machine learning capabilities. The system is patient-tailored, and is constantly learning the patient’s voice and providing personalized, seamless and effortless monitoring.

Cordio’s goal is to identify and mitigate condition worsening by helping physicians prevent patient deterioration and hospitalization while keeping the patient involved and informed.

Funding history · 7 rounds · $20.6M total

2025-10
Undisclosed
2024-12
Undisclosed
2024-06
Undisclosed
2024-01
2021-12
Grant $889K

Q&A

What is Cordio Medical's primary focus?
Cordio Medical provides medical-grade solutions for monitoring health conditions by analyzing voice samples recorded via a smartphone app, utilizing sophisticated algorithms for near real-time monitoring and early detection of condition deterioration.
How many employees does Cordio Medical have?
Cordio Medical has 11-50 employees.
What is the total amount of funding Cordio Medical has raised to date?
Cordio Medical has raised a total of $20,598,888 USD.
Which investors participated in Cordio Medical's funding round in June 2022?
In June 2022, investors in Cordio Medical included.
Which investor participated in Cordio Medical's funding round in January 2024?
In January 2024, investors in Cordio Medical included Hadasit.
Which investor participated in Cordio Medical's funding round in June 2024?
In June 2024, Iron Nation participated as an investor in.
What is Cordio Medical's current funding stage?
Cordio Medical is currently in Series C funding stage.
What technologies does Cordio Medical utilize?
Cordio Medical utilizes Artificial Intelligence, Voice & Speech Recognition, Machine Learning, Platforms & Interfaces, Mobile, Data Storage, and Cloud technologies.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcarePatient Remote Monitoring
Technologies
Artificial IntelligenceVoice & Speech RecognitionMachine LearningPlatforms & InterfacesMobileData StorageCloud
Target customers
Healthcare & Life SciencesHealthcareProvidersPatients
Business model
B2CB2B

Highlights

1 Patents

Tags

home-caredigital-healthcareearly-detectionmobile-applicationsmhealthnon-invasiverespiratoryremote-monitoringheart-failurecloud-baseddata-analyticscardiologypersonalizationartificial-intelligencechronic-patientsspeech-analyticssignal-processingmachine-learningpersonalized-medicinediagnosticspatient-care
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitecordio-med.com
LinkedInlinkedin.com/company/10476362

Identifiers & details

Former namesCountingApp Medical
Founded2013-10
Employees (exact)34

Radar intelligence

Patents

EPO18

Web history (Wayback)

Domaincordio-med.com

Certificate / subdomain footprint

Subdomains2